MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

TMP778

CAS No. : 1422053-04-0

MCE 站：TMP778

产品活性：TMP778 是一种有效的、RORγt 的选择性逆向激动剂，其 FRET 检测出的 IC₅₀ 值为 7 nM。

研究领域：Metabolic Enzyme/Protease

作用靶点：ROR

In Vitro: It is found that TMP778 at >2.5 μM starts to show toxic effects on cell growth, which however is not RORγt-dependent, since the proliferation of RORγt-deficient T cells cultured under Th17 cell-polarizing conditions is also decreased. Otherwise, these inhibitors do not show inhibitory effects on cell proliferation or RORγt expression or its nuclear translocation, but efficiently inhibited IL-17 production. TMP778 has a much broader dose range and efficiently decreased IL-17 production, consistent with its higher binding affinity for RORγt. These data indicate that TMP778 is the RORγt inhibitor that most potently reduced IL-17 production.

In Vivo: All three compounds (e.g., TMP778) delay the onset of disease and substantially reduce the severity of disease progression compared to control-treated mice. Consistent with in vitro results, TMP778 treatment causes the most pronounced effect on the disease phenotype. This treatment not only decreases the number of mononuclear cells infiltrating the central nervous system (CNS), but also most strongly reduces the percentage of IL-17⁺ T cells in the CNS (including IL-17⁺ IFNγ⁺). There is no significant change in the percentage IFNγ⁺ IL-17-T cells in the CNS among all groups, indicating that of the inhibitors affects Th1 responses. TMP778 strongly inhibits Th17 cell generation, reduces IL-17 production from differentiated Th17 cells, and also dramatically ameliorates the progression of EAE.

相关产品：Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Metabolism/Protease Compound Library  |  Small Molecule Immuno-Oncology Compound Library  |  T0901317  |  Nobiletin  |  SR3335  |  SR1078  |  SR1001  |  GSK805  |  3-Oxo-5β-cholanoic acid  |  SR0987  |  TMP920  |  Neoruscogenin  |  S18-000003  |  RORγt Inverse agonist 8  |  Methyl-3β-hydroxycholenate

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。